This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hardy, R. D.
Right arrow Articles by Ramilo, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hardy, R. D.
Right arrow Articles by Ramilo, O.

 Previous Article  |  Next Article 

Infection and Immunity, February 2002, p. 649-654, Vol. 70, No. 2
0019-9567/01/$04.00+0     DOI: 70.2.649-654.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Mycoplasma pneumoniae Induces Chronic Respiratory Infection, Airway Hyperreactivity, and Pulmonary Inflammation: a Murine Model of Infection-Associated Chronic Reactive Airway Disease

Robert D. Hardy,1* Hasan S. Jafri,1 Kurt Olsen,1 Jeanine Hatfield,1 Janie Iglehart,1 Beverly B. Rogers,1 Padma Patel,2 Gail Cassell,2 George H. McCracken,1 and Octavio Ramilo1

Departments of Pediatric Infectious Diseases and Pathology, University of Texas Southwestern Medical Center, Dallas, Texas 75390,1 Diagnostic Mycoplasma Laboratory, University of Alabama, Birmingham, Alabama 352032

Received 23 July 2001/ Returned for modification 21 September 2001/ Accepted 19 November 2001

Because chronic Mycoplasma pneumoniae respiratory infection is hypothesized to play a role in asthma, the potential of M. pneumoniae to establish chronic respiratory infection with associated pulmonary disease was investigated in a murine model. BALB/c mice were intranasally inoculated once with M. pneumoniae and examined at 109, 150, 245, 368, and 530 days postinoculation. M. pneumoniae was detected in bronchoalveolar lavage fluid by culture or PCR in 70 and 22% of mice at 109 and 530 days postinoculation, respectively. Lung histopathology was normal up to 368 days postinoculation. At 530 days, however, 78% of the mice inoculated with M. pneumoniae demonstrated abnormal histopathology characterized by peribronchial and perivascular mononuclear infiltrates. A mean histopathologic score (HPS) at 530 days of 5.1 was significantly greater (P < 0.01) than that for controls (HPS score of 0). Serum anti-M. pneumoniae immunoglobulin G was detectable in all of the mice inoculated with M. pneumoniae and was inversely correlated with HPS (r = -0.95, P = 0.01) at 530 days postinoculation. Unrestrained whole-body plethysmography measurement of enhanced pause revealed significantly elevated airway methacholine reactivity in M. pneumoniae-inoculated mice compared with that in controls at 245 days (P = 0.03) and increased airway obstruction at 530 days (P = 0.01). Murine M. pneumoniae respiratory infection can lead to chronic pulmonary disease characterized by airway hyperreactivity, airway obstruction, and histologic inflammation.


* Corresponding author. Mailing address: Department of Pediatrics, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390-9063. Phone: (214) 648-3720. Fax: (214) 648-2961. E-mail: rhardy{at}mednet.swmed.edu.

Editor: E. I. Tuomanen


Infection and Immunity, February 2002, p. 649-654, Vol. 70, No. 2
0019-9567/01/$04.00+0     DOI: 70.2.649-654.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Salvatore, C. M., Techasaensiri, C., Tagliabue, C., Katz, K., Leos, N., Gomez, A. M., McCracken, G. H., Hardy, R. D. (2009). Tigecycline Therapy Significantly Reduces the Concentrations of Inflammatory Pulmonary Cytokines and Chemokines in a Murine Model of Mycoplasma pneumoniae Pneumonia. Antimicrob. Agents Chemother. 53: 1546-1551 [Abstract] [Full Text]  
  • Annagur, A., Kendirli, S. G., Yilmaz, M., Altintas, D. U., Inal, A. (2007). Is There Any Relationship Between Asthma and Asthma Attack in Children and Atypical Bacterial Infections; Chlamydia Pneumoniae, Mycoplasma Pneumoniae and Helicobacter Pylori. J Trop Pediatr 53: 313-318 [Abstract] [Full Text]  
  • Nisar, N., Guleria, R., Kumar, S., Chand Chawla, T., Ranjan Biswas, N. (2007). Mycoplasma pneumoniae and its role in asthma. Postgrad. Med. J. 83: 100-104 [Abstract] [Full Text]  
  • Xu, X., Zhang, D., Zhang, H., Wolters, P. J., Killeen, N. P., Sullivan, B. M., Locksley, R. M., Lowell, C. A., Caughey, G. H. (2006). Neutrophil histamine contributes to inflammation in mycoplasma pneumonia. JEM 203: 2907-2917 [Abstract] [Full Text]  
  • Bakshi, C. S., Malik, M., Carrico, P. M., Sellati, T. J. (2006). T-bet Deficiency Facilitates Airway Colonization by Mycoplasma pulmonis in a Murine Model of Asthma. J. Immunol. 177: 1786-1795 [Abstract] [Full Text]  
  • Toews, G. B. (2005). Impact of bacterial infections on airway diseases. ERR 14: 62-68 [Abstract] [Full Text]  
  • Johnston, S. L., Martin, R. J. (2005). Chlamydophila pneumoniae and Mycoplasma pneumoniae: A Role in Asthma Pathogenesis?. Am. J. Respir. Crit. Care Med. 172: 1078-1089 [Abstract] [Full Text]  
  • Fonseca-Aten, M., Salvatore, C. M., Mejias, A., Rios, A. M., Chavez-Bueno, S., Katz, K., Gomez, A. M., McCracken, G. H. Jr, Hardy, R. D. (2005). Evaluation of LBM415 (NVP PDF-713), a Novel Peptide Deformylase Inhibitor, for Treatment of Experimental Mycoplasma pneumoniae Pneumonia. Antimicrob. Agents Chemother. 49: 4128-4136 [Abstract] [Full Text]  
  • Sohn, M. H., Lee, K. E., Choi, S. Y., Kwon, B. C., Chang, M. W., Kim, K.-E. (2005). Effect of Mycoplasma pneumoniae Lysate on Interleukin-8 Gene Expression in Human Respiratory Epithelial Cells. Chest 128: 322-326 [Abstract] [Full Text]  
  • Fonseca-Aten, M., Rios, A. M., Mejias, A., Chavez-Bueno, S., Katz, K., Gomez, A. M., McCracken, G. H. Jr., Hardy, R. D. (2005). Mycoplasma pneumoniae Induces Host-Dependent Pulmonary Inflammation and Airway Obstruction in Mice. Am. J. Respir. Cell Mol. Bio. 32: 201-210 [Abstract] [Full Text]  
  • Waites, K. B., Talkington, D. F. (2004). Mycoplasma pneumoniae and Its Role as a Human Pathogen. Clin. Microbiol. Rev. 17: 697-728 [Abstract] [Full Text]  
  • Rios, A. M., Mejias, A., Chavez-Bueno, S., Fonseca-Aten, M., Katz, K., Hatfield, J., Gomez, A. M., Jafri, H. S., McCracken, G. H. Jr., Ramilo, O., Hardy, R. D. (2004). Impact of Cethromycin (ABT-773) Therapy on Microbiological, Histologic, Immunologic, and Respiratory Indices in a Murine Model of Mycoplasma pneumoniae Lower Respiratory Infection. Antimicrob. Agents Chemother. 48: 2897-2904 [Abstract] [Full Text]  
  • Blasi, F. (2004). Atypical pathogens and respiratory tract infections. Eur Respir J 24: 171-182 [Abstract] [Full Text]  
  • Simmons, W. L., Dybvig, K. (2003). The Vsa Proteins Modulate Susceptibility of Mycoplasma pulmonis to Complement Killing, Hemadsorption, and Adherence to Polystyrene. Infect. Immun. 71: 5733-5738 [Abstract] [Full Text]  
  • Hardy, R. D., Rios, A. M., Chavez-Bueno, S., Jafri, H. S., Hatfield, J., Rogers, B. B., McCracken, G. H., Ramilo, O. (2003). Antimicrobial and Immunologic Activities of Clarithromycin in a Murine Model of Mycoplasma pneumoniae-Induced Pneumonia. Antimicrob. Agents Chemother. 47: 1614-1620 [Abstract] [Full Text]  
  • Chu, H. W., Honour, J. M., Rawlinson, C. A., Harbeck, R. J., Martin, R. J. (2003). Effects of Respiratory Mycoplasma pneumoniae Infection on Allergen-Induced Bronchial Hyperresponsiveness and Lung Inflammation in Mice. Infect. Immun. 71: 1520-1526 [Abstract] [Full Text]